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Abstract: Communicating effectively with patients who have advanced cancer is one of 
the greatest challenges facing physicians today. Whilst guiding the patient through complex 
diagnostic and staging techniques, treatment regimens and trials, the physician must translate 
often imprecise or conflicting data into meaningful personalized information that empowers the 
patient to make decisions about their life and body. This requires understanding,   compassion, 
patience, and skill. This narrative literature review explores current communication practices, 
information preferences of oncology patients and their families, and communication   strategies 
that may assist in these delicate interactions. Overwhelmingly, the literature suggests that whilst 
the majority of patients with advanced cancer do want to know their diagnosis and receive 
detailed prognostic information, this varies not only between individuals but also for a given 
individual over time. Barriers to the delivery and understanding of information exist on both 
sides of the physician–patient relationship, and family dynamics are also influential. Despite 
identifiable trends, the information preferences of a particular patient cannot be reliably predicted 
by demographic, cultural, or cancer-specific factors. Therefore, our primary recommendation is 
that the physician regularly asks the patient what information they would like to know, who else 
should be given the information and be involved in decision making, and how that information 
should be presented.
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Introduction
Physicians caring for patients with advanced cancer are increasingly expected to not 
only remain up to date with the latest diagnostic and staging modalities, treatment 
regimens and trials, but to also communicate effectively with patients and families 
regarding these matters. The conversations that punctuate each patient’s cancer jour-
ney are technically complex and have intense social, psychological, and spiritual 
significance,1 requiring understanding, compassion, patience, and skill. The aim of 
this narrative literature review is to explore current communication practices and 
how both physician and patient factors influence these, how patients interpret and use 
the information communicated to them, and patient preferences for the delivery of 
information. Strategies and guidelines for conducting such delicate conversations and 
the role of training are also discussed.
A literature search using PubMed and the terms ‘advanced cancer/malignancy’, 
‘metastatic cancer/malignancy’ or ‘terminal cancer/malignancy’ and   ‘communication’ 
was conducted. Hand-searching of reference lists of relevant articles was also 
  performed. English-language qualitative and quantitative studies have been included. Cancer Management and Research 2011:3 submit your manuscript | www.dovepress.com
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As doctor–patient communication is the focus of this review, 
the nursing and allied health literature was not specifically 
searched. This paper is written from a Western perspective, 
and as most of the literature retrieved pertains to disclosing 
diagnosis and discussing prognosis, this is the main focus 
of the review.
Current communication practices
Communication with oncology patients has changed 
  dramatically over the last 50 years. While previously the very 
diagnosis of cancer was withheld from most patients, it is now 
almost always disclosed,2,3 although in non-Western countries 
this may not be common practice.4–7 The survival implication 
of that diagnosis however – the prognosis – remains poorly 
communicated. A study of 140 patients with metastatic 
cancer in the Netherlands found only 39% were told their 
prognosis by their oncologist.8 Similarly, an Australian study 
of patients with breast cancer or melanoma found only 27% 
were given a prognosis during their initial oncology consulta-
tion, while 57% desired this information.9
Oncology patients generally tend to overestimate 
their prognosis. In the Study to Understand Prognoses 
and   Preferences for Outcomes and Risks of Treatments 
  (SUPPORT), 82% of 917 patients hospitalized with meta-
static cancer in the United States estimated their 6-month 
survival more optimistically than their physician, and in over 
half of this was by a factor of 40% or more.10 Other studies 
have demonstrated high rates of confusion in advanced cancer 
patients as to whether their cancer is curable or incurable.11,12 
There are also high rates of discordance between patients 
and their families, with one Australian survey finding in 
over a third of those with incurable cancer only one of the 
patient–carer pair understood that their treatment was not 
intended to cure.13
Patient–physician disparity regarding understanding of 
prognosis may be due to a range of factors (Table 1).
Physician factors
Firstly, the physician may choose not to disclose prognostic 
information. In many cases, life expectancy is only 
discussed if the patient asks, and in some cases not even if 
requested.14,15 In a large American survey, while physicians 
felt able to formulate a prognosis for 96% of their advanced 
cancer patients, they stated they would only communicate 
this prognosis to 37%, even if a survival estimate were 
requested. They would not communicate any survival 
estimate to 22% of patients and would communicate a 
different estimate to the one they had formulated to 40%, of 
which 70% would be optimistically disparate.16 If patients 
are optimistic then many physicians reinforce optimistic 
views. Most avoid trying to be specific when asked for 
prognostic information, particularly if generalists compared 
with specialists.14
The reluctance of physicians to disclose prognostic 
information may be due to low confidence in their   ability 
to prognosticate accurately. As effective therapies for 
  previously fatal diseases were discovered, medical 
  education and literature have increasingly focused on 
diagnosis and   treatment, with a resultant loss of the skill 
of prognostication.17 Many physicians therefore find 
prognostication difficult and   stressful, and feel inadequately 
trained to prognosticate.14
It is true that prognostic estimates in terminally ill 
patients are often incorrect and usually optimistic,18–22 with 
one report of estimates being over three times longer than 
actual survival.16 The experience and specialty of physician 
as well as the nature of the physician–patient relationship can 
influence the accuracy of a clinical prediction of survival.19,23 
Accuracy may improve closer to death20,21 and with the 
addition of calculated prognostic indices such as the palliative 
prognostic index.24
Physicians may also feel they have inadequate skills or 
training to discuss prognosis. They may fear destroying hope 
or provoking emotional distress. They may feel they have 
inadequate training or time to attend to a patient’s emotional 
needs, and may fear being blamed by patients and relatives. 
They may have feelings of inadequacy or hopelessness 
regarding the unavailability of further curative treatment, 
Table 1 Factors that may contribute to doctor–patient disparity 
in understanding of prognosis
Physician factors Patient factors
Reluctance to disclose prognosis
Low confidence in ability  
to prognosticate accurately
Low confidence in ability to  
discuss prognosis
Insufficient time
Fear of destroying hope
Fear of provoking emotional  
distress
Fear of being blamed
Fear of confronting own emotions
Fear of confronting death
Feelings of inadequacy
Burnout and compassion fatigue
Cultural expectations
Overestimation of patient  
understanding
Ambiguous attitude to  
knowing prognosis
Denial
Distress
Preferring to entrust details  
to experts
Fear of causing offense by 
questioning
Fear of wasting the physician’s   
time
Fear of losing hope
Cultural expectations
Difficulty understanding  
terminology or certain  
information formatsCancer Management and Research 2011:3 submit your manuscript | www.dovepress.com
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may worry about containing their own emotions, and may 
have to confront their own fears about death.14,25–29 Clinicians 
who care for dying patients are also at risk of burnout and 
compassion fatigue, which may lead to emotional exhaustion, 
diminished empathy, and avoidance of emotionally difficult 
clinical situations.30
Physicians’ concerns about discussing prognosis may be 
well founded. Patients can be traumatized when bad news is 
delivered bluntly,31 and major changes in prognosis may be 
destabilizing.32 However, if potentially distressing information 
is withheld from patients then they are given no opportunities 
to reveal their own fears and worries. They may feel isolated 
and worried that nothing will be done to help, and may imagine 
a more horrible outcome than awaits them. As Fallowfield 
asserts, “precisely when the majority of people are most in 
need of truthful communication and support, when they have 
changing thoughts and feelings and need to make important 
decisions, a conspiracy of silence may envelop them and the 
resulting anxiety and tension may hinder adjustment”.29
Conversely, prognostic information that is tailored to a 
patient’s preferences has potential to improve their   psychological 
wellbeing.1,33 Tailored prognostic information has been found 
to result in higher satisfaction with care, lower anxiety and 
depression scores, and even improved cognitive function.34–36 
Potentially distressing information delivered sensitively can be 
used to reassure by allowing planning   around symptom progres-
sion and actual mode of death, such as   preparing specific crisis 
orders for catastrophic hemorrhage.37,38
Cultural elements also influence physician communi-
cation. A study of palliative medicine physicians showed 
those from South America and Europe were far less likely 
than their Canadian counterparts to believe that the majority 
of their patients wanted to know about the terminal stage 
of their illness; 18% and 26% versus 93%, respectively.3 
Oncologists practicing in non-Western countries may be 
more likely to wait for the patient to ask before disclosing 
a poor prognosis.27
Patient factors
Another reason there may be disparity in patient–physician 
understanding of prognosis is that the physician may be 
  discouraged from disclosing information either by the patient 
or by their family. The phenomenon of collusion has been 
described by oncologist and ethicist Paul Helft as a “spoken 
or unspoken agreement” between the physician and patient, 
entered into “to avoid or delay discussing a definitive,   numerical 
prognostic estimate of life expectancy”.39 Patients with terminal 
cancer have identified a sense of ambiguity regarding   prognostic 
information, wherein they want to be told but simultaneously 
do not want to know.40 Discussion may tend to focus around 
the treatment calendar and ignore the long term. This approach 
can provide optimism, which helps the patient to endure the 
treatment phase but may lead to regret later.41
Reasons why patients may choose not to ask their 
  physician questions about their malignancy and treat-
ment may include faith in the physician as an expert and 
hence relief in not being required to understand the details 
  personally, fear of causing offence by questioning, and not 
wanting to waste the physician’s time with questions when 
other patients are waiting. Additionally, they may not ask 
questions in an attempt to preserve hope and present a ‘brave 
face’, although in some patients, preserving hope conversely 
translates to more active information seeking, particularly 
regarding alternative therapies.32
In cultures where knowledge of diagnosis and prognosis 
is thought to be detrimental to the patient’s wellbeing,   family 
members may prefer the physician not to speak frankly with the 
patient.42–44 Oncologists practicing in non-Western countries 
may be more likely to comply with such family requests.27
How patients interpret what is said
Lastly, there may be patient–physician disparity in the under-
standing of prognosis if patients have misunderstood the 
information that has been provided. Medical terminology 
and various formats of presenting prognosis and probabilities 
can be difficult for patients to comprehend.45,46 Words that 
carry different meanings in nonmedical conversation, such 
as “progressing” and “positive/negative” tests, may cause 
confusion.47–49 Distress and denial are known to reduce the 
amount of information patients retain after conversations with 
physicians.50,51 Data from the Australian and American contexts 
have shown that age and gender do not appear to be significant 
factors in comprehension, but patients who have not completed 
secondary school and for whom English is a second language 
are less likely to have concordance with their physician.51,52
Physicians may overestimate patient understanding,53 
and Australian oncologists have been reported to seek 
  confirmation of understanding in only 10% of consultations.35 
Patients may be reluctant to ask for clarification, particularly 
when there is a language barrier.54
How information influences 
decision-making
Regardless of the reliability of the information gleaned, 
patients and their families do use it to make important decisions 
regarding the nature of their treatment, estate management, Cancer Management and Research 2011:3 submit your manuscript | www.dovepress.com
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and funeral planning, in addition to social planning including 
summoning relatives to visit from out of town.45,55 When the 
information is inaccurate or based on hopes rather than facts, 
their decisions may not reflect their true values. Similarly, 
overly optimistic prognostic estimates may influence treatment 
decisions made by physicians, with resultant futile interven-
tions such as chemotherapy in the last few weeks of life, no 
discussion of palliative care, and late referrals to hospice.56
In the SUPPORT study, cancer patients who were over 
90% sure they would live for at least 6 months were over two 
and a half times more likely to favor life-extending therapy 
over symptom-focused care compared with those who thought 
there was even a 10% chance they would not live 6 months. 
Those preferring life-extending therapy were more likely to 
undergo aggressive therapy, but their 6-month survival was 
no better than the more pessimistic group. Instead they were 
more likely to have a readmission to hospital, an attempted 
resuscitation, or a death whilst receiving ventilatory assis-
tance.10 Another American study found patients who were 
aware they are terminally ill were more likely to discuss end-
of-life care with their physician and more likely to receive care 
that was consistent with their wishes. Importantly, patients 
with advanced cancer who received life-extending care in the 
last week of life were rated by caregivers as having higher 
physical and psychological distress and poorer quality of life 
than those who received symptom-directed care, regardless 
of the patient’s treatment preferences.57 End-of-life discus-
sions have also been associated with lower medical costs in 
the final week of life.58 Discussions about no further curative 
treatment and transition to hospice care, however, have been 
reported by American oncologists to be those they find most 
difficult.27
Both patients and carers identify psychosocial preparation 
for death as an important part of a ‘good death’. This includes 
saying goodbye to important people, resolving unfinished 
business matters and having a general sense of completion. 
Undergoing aggressive therapies in the last days and weeks 
of life may reduce the patient’s ability and opportunities to 
engage in these activities, which take time and may be both 
physically and psychologically taxing.59 Understanding 
  prognosis has implications for carers also, with evidence 
of preparedness for the death of a loved one decreasing 
  long-term anxiety rates and facilitating grief resolution.60,61
The literature suggests, therefore, that due to a lack of 
disclosure or subsequent misunderstanding of information 
disclosed, physicians and patients often do not share the 
same understanding of the patient’s prognosis. Given the 
potentially profound influence of this information on patient 
decision making around not only treatment but social and 
financial matters, it is crucial for physicians to ensure that the 
patient has opportunity to receive and comprehend accurate, 
clear, and personalized information. To achieve this goal, 
physicians need to know which pieces of information to 
convey, how to convey them, and when.
Patient preferences for information 
delivery
Content and timing: what patients want 
to hear and when
Over one-third of patients with advanced cancer feel that they 
have high unmet needs with respect to medical information 
and communication.62 The majority of oncology patients 
indicate a desire to know their diagnosis and the extent of 
disease, their treatment options, and even relatively rare side 
effects of these treatments.63,64
Most oncology patients also want to know their 
prognosis47,64 and have rated prognostic information as the 
most important element of communication – more important 
than diagnostic disclosure or treatment information.65 A large 
UK study of 2850 patients with cancer of various clinical 
stages showed 85% wanted the doctor to provide as much 
information as possible.47 A desire for information may not 
be true for all patients or all cultural groups however.4,47 
Equally, a patient’s desire for information is not always 
accompanied by a desire to be involved in clinical decision 
making, as some find this burdensome.32,66
Oncology patients want physicians to communicate 
  honestly with them about the severity of their disease40,46,67 but 
to also be optimistic.38,68 In a study of Australian women with 
metastatic breast cancer, Butow and colleagues summarized 
that when these women do request prognostic information 
“they are rarely seeking statistics on life expectancy, but 
rather reassurance and hope, forewarnings concerning the 
impact of side effects and symptoms on their lives, and/
or guidance regarding practical decisions they may need to 
make”.69
Evidence suggests that female patients,47,66 those with 
better education,70 and those in the first six decades of life 
may desire more information than their counterparts.36,47 
Certain types of cancer may also correlate with higher infor-
mational needs; for example, ovarian as compared to breast.70 
Higher depression scores are associated with wanting to know 
the shortest time to live without treatment.64
Despite these trends, it is important to note that   demographics 
do not reliably predict individual informational preferences, 
and studies have found contradicting results.9,71 Physicians Cancer Management and Research 2011:3 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
195
What do patients with advanced cancer want to know?
must attempt to engage with their patients on a personal level, 
taking into account their unique character, experiences, and 
social setting, as well as their fears and hopes.
Many patients want to negotiate if and when expected 
survival is discussed,64,69,72 and there is variation in patients’ 
beliefs as to who should initiate these conversations.50 
Patients have indicated that physicians should not assume 
they wish to be told prognosis but permission to discuss 
should be sought periodically,64 although even this is not a 
simple matter. When American patients with either advanced 
cancer or severe chronic obstructive pulmonary disease 
and their families were asked “how much information do 
you want?”, all initially replied that they wanted “all the 
  information” but detailed interviews subsequently revealed 
variation in desire and readiness for explicit prognostic 
information.73 Information, decision making, and indeed care 
preferences may fluctuate over the course of an illness and 
may also differ between patients and their carers.32,66,74
Australian research suggests that caregivers more than 
patients themselves want details regarding the terminal 
phase. Patients are keen to know that pain will be controlled 
as their disease progresses, but for other symptoms, they 
only want reassurance of support if and when they arise. In 
contrast, caregivers request detailed information about future 
  symptoms, mode of death, and whether caring for their loved 
one at home would be a realistic option.75
Some evidence suggests a general trend of patients   desiring 
less detail as time goes on.66 Other studies show informa-
tional needs of patients and their families   diverging as cancer 
  progresses, with patients becoming more focused on symptom 
management and family remaining interested in prognosis. 
Patients and family members may shelter each other from 
knowledge as the illness progresses, with   communication 
between them becoming less verbally explicit.40 Conversely, 
the communication style of relatives towards people other than 
the patient becomes more open and explicit, particularly about 
dying itself, as the death of the patient draws near.76
Key players: who patients want  
to be involved
Patients want their prognostic information to be delivered by 
an expert physician who is directly in charge of their care40 
and preferably a physician who they trust, who sees them 
as a whole person, and who is comfortable talking about 
death and the patient’s fears.59,46 Patients are more likely to 
perceive information given as unclear when delivered by a 
house medical officer compared with a specialist or general 
practitioner, reflecting the importance of experience and 
training.43 There is conflicting data as to patient preferences 
for having a nurse or other health professional accompany 
them during consultations,9 although ensuring a team 
approach and minimizing the number of people presenting 
information may help to avoid exposure to contradictory 
information, which provokes anxiety.32,71
Family members frequently provide significant emotional 
support along the patient’s cancer journey and help them to 
remain hopeful,77 but not all patients desire a family   member 
to be present when receiving new medical information.9 
While most patients find this a source of support, others want 
to be at liberty to discuss sensitive issues with their physician 
without burdening family and to filter information for their 
family members.50 The majority of oncology patients want 
family members to be involved in decision making but not 
necessarily at all points of their illness.78
Cultural issues may influence the degree to which 
  oncology patients want their families to be involved.6,79 Many 
non-Western and indigenous cultures have a family-centered 
model of medical decision making, rather than a patient auton-
omy model.80,81 They may believe family members should 
have access to accurate and honest information regarding the 
patient’s diagnosis and prognosis, but this should be withheld 
from the patient. They may also believe that family rather than 
the patient should make decisions about treatment; including 
the use of life support. Thus, well meaning attempts to protect 
the autonomy of the individual, with advanced care directives 
for example, may actually oppose their deepest values.81
Style of delivery: verbal and nonverbal 
aspects
The communication style of the physician influences the   content 
and nature of patients’ responses and their willingness to raise 
issues which are important to them. Acknowledging emotion 
is a central component of showing empathy and facilitating 
discussion about patients’ concerns, which may ameliorate 
distress even if the problems themselves cannot be solved.82 
Oncology patients do not often express negative emotions to 
their oncologists83 but report an increased need to talk about 
their worries and fears.66 Audio-recordings of consultations in 
America have found empathic   opportunities are present in 37% 
of conversations, but oncologists give empathic responses less 
than one-third of the time; a low rate which likely discourages 
any further expression of emotion by patients.84 Similar rates 
have been found among nonphysician clinicians such as nurse 
practitioners and physician assistants.85
Many patients with advanced cancer want their physician 
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will be medically uninteresting and less rewarding for their 
physicians but want them to continue their commitment and 
provide options for care, albeit palliative.72 Patients want to 
be acknowledged as individuals, given an opportunity to 
ask questions and be asked at regular intervals what their 
information preferences are.32,77
Many patients do not want to be told a timeframe, but if 
prognosis is discussed directly, most desire this to be in the 
  format of how long the average person with their condition 
would live.86 Patients generally prefer positively presented 
information such as “chance of living × years” rather than 
“chance of dying × time”.64 Making just one pessimistic 
statement during the consultation has been shown to ensure 
effective communication of a poor prognosis, but physicians 
can simultaneously emphasize optimistic aspects of the 
patient’s case to foster hope.87 Other strategies to maintain 
hope include setting achievable goals, emphasizing symptom-
atic therapies that can be offered, and reassuring that there 
will be continuity of care and support throughout the course 
of the patient’s disease.40,75,77,88
Patients also report that words and numbers are perceived to 
be more optimistic and less harsh than pie charts and graphs.64 
Up to 80% appreciate the occasional use of humor but feel 
the use of euphemisms (eg, ‘pass away’ rather than ‘die’) 
do not facilitate hope.77 The use of metaphors and analogies 
however (eg, likening a chemotherapy regimen to a   marathon) 
can improve patient understanding and   satisfaction with 
  communication, due to the incorporation of everyday concepts 
that are more familiar to patients than medical terminology.89
Where language barriers exist, some patients prefer 
translation to be performed by family members who are 
trusted and accessible, while others prefer professionals 
who aren’t emotionally invested in the conversation.54,71 
‘Cultural interpreters’, such as Aboriginal health workers, 
may also be helpful in providing guidance in cultural norms 
and facilitating understanding of illness concepts that may be 
underpinned by completely different worldviews.90,91
Nonverbal communication is also important. The 
vast majority of oncology patients prefer face-to-face 
communication,9 and randomized controlled trials of 
  physicians’ posture whilst breaking bad news have shown 
patients prefer physicians to sit rather than stand, and   perceive 
those that do so as more compassionate.92,93 Patients with 
advanced cancer perceive physician behaviors such as making 
eye contact (if culturally appropriate) and not   taking phone 
calls to convey a sense of being present and not hurried. This is 
felt to be more important than the actual amount of time spent. 
Some patients appreciate physical touch and sitting on the 
patient’s bed rather than on a chair, but hugging is   generally 
considered to be outside professional boundaries.72,94
The concept of using a ‘treatment broker’ has been 
  suggested, where a third party who is trusted by both the doctor 
and patient assists both to clarify their   understanding, assump-
tions, and expectations.41 Family members may often infor-
mally fulfill this role, though specialized nursing or   support 
staff who can remain objective may best perform it. Addition 
of written communications and audiocassette   recording of 
the consultation improves recall of the information given and 
overall patient satisfaction.95 Provision of a question prompt 
list before a palliative medicine   consultation results in patients 
asking twice as many questions and more discussion of prog-
nostic and end-of-life issues, although may not lower patient 
anxiety levels or improve their   satisfaction scores.96
Alternative sources of information, such as books, 
pamphlets, broadcast media, telephone services, and the 
Internet, have been found to decrease uncertainty and give 
some sense of control, particularly for younger patients or 
when communication with the health professional was felt to 
be unsatisfactory.40,70 Immigrants appreciate these resources 
when available in their native language.54 Physician recom-
mendation of particular reliable websites is appreciated.72 
Patients have reported frustration and anxiety with nonin-
dividualized materials, however, in which they struggle to 
discern which information is relevant to their own case.32 
It is also important to note that patients, particularly women, 
seek information from one another with regards to personal 
experiences of cancer and cancer treatment.32
Improving communication skills
Good communication is essential for health professionals 
as it improves health care outcomes and has been shown to 
prevent burnout and increase job satisfaction.97,98 Increased 
skills and confidence in discussing poor prognostic infor-
mation with patients has been reported by physicians who 
have undertaken training in the ‘SPIKES’ protocol99 and 
workshops such as ‘Oncotalk’.100 A Cochrane systematic 
review concluded that communication skills do not reli-
ably improve with experience alone, but that there is some 
evidence from three studies to suggest intensive multiday or 
modular communications skills training can have beneficial 
effects on communication practices in professionals working 
with cancer patients. It is not clear if this is reproducible for 
other training facilitators or participants.101 Subsequently 
published results of a 12-month follow-up of 160 oncologists 
showed enduring effects over time.98 Such courses, however, 
are expensive and require a significant time commitment. Cancer Management and Research 2011:3 submit your manuscript | www.dovepress.com
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Promising results have also been seen with a novel training 
approach using computer simulated standardized patients, 
although these lack nonverbal communication and emotional 
cues, which are so essential in the real world.102
While available training courses are often directed at 
oncologists and oncology fellows, many patients have their 
diagnosis of cancer communicated by general practitioners 
or surgeons.96,103 General practitioners are often also used as a 
sounding board for decisions and to verify information given 
by other physicians. Hence there is a need for   medical schools 
and specialty colleges to include communication skills 
  training in their core curricula. Clinical practice guidelines1,71 
provide all clinicians caring for patients with cancer and 
their families with evidence-based, practical approaches for 
conducting difficult conversations.
Further research is required into communication with 
oncology patients and their families, as well as the most 
effective method of teaching clinicians how to communicate 
effectively in keeping with patient preferences. Training 
courses must result in skill development that is transferrable 
to the everyday clinical setting and that endures over time.
Summary
Overwhelmingly, the literature suggests that whilst the 
majority of oncology patients do want detailed information, 
this varies not only between individuals, but also for a given 
individual over time. This narrative review highlights trends 
emerging from existing evidence, but even so, the informa-
tion preferences of an individual cannot be reliably predicted 
by either demographic or cancer-specific factors.
Communication between the physician and oncology 
patient is highly contextualized and complex. Therefore, our 
primary recommendation is that the physician regularly asks 
the patient what information they would like to know, who else 
should be given the information and be involved in decision 
making, and also how that information should be presented.
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